The public offering, led by the OYAK Investment consortium, was carried out with a fixed-price bid collection and off-exchange sales method. While the demand for shares, which corresponds to 6.7 times the total shares offered to the public, is generated, 7.9 times the shares allocated to domestic individual investors in the public offering, 9.7 times the shares allocated to domestic institutional investors, 2,2 times the shares allocated to foreign institutional investors. 0 times the demand and 1.7 times the shares allocated to the company’s employees. As a result of the intense interest, the total public offering reached TL 738.1 million in the offering, in which the right to sell additional shares was also exercised.
In the public offering carried out by Gen İlaç with the proportional distribution method to domestic individual investors, 51 thousand 73 investors demanded a nominal amount of 21 million 250 thousand liras allocated to domestic individual investors.
CAPITAL INCREASE AND COMMON SALES METHODS USED TOGETHER
In the public offering of Gen Pharmaceuticals, capital increase and joint sales methods were used together. While a nominal amount of 50,000,000 TL shares were sold from the capital increase, 18,750,000 TL nominal shares, including additional sales, were also sold through the joint sale method, while at the end of the book-building process completed, shares with a nominal amount of 68.750.000 TL, corresponding to 22.92 percent of the total capital, were sold to the public. was presented. Thus, the capital of the company increased from TL 250,000,000 to TL 300,000,000.
In the public offering of Gen Pharmaceuticals, the demand was 6.7 times the total public offering size of the shares with a nominal value of 62.500.000 TL, and all the shares with a nominal value of 68.750.000 TL, including the additional sale offered for sale, were sold.
34 percent of the shares offered to the public were allocated to domestic individual investors, 1 percent to company employees, 35 percent to domestic corporate and 30 percent to foreign institutional investors. As a result of the public offering, 35 percent of the shares were distributed to domestic individual investors, 1 percent to company employees, 38 percent to domestic institutional investors and 25 percent to foreign institutional investors.
The shares of the company offered to the public will start to be traded on Borsa Istanbul Yıldız Market with a price of 10.75 liras and the code ‘GENIL’ in the coming days.